Pliant Therapeutics Inc. (PLRX)
NASDAQ: PLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
PLRX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $61.30M
- EPS (TTM)
- -$1.44
- Dividend yield
- None
- 52-week range
- 0.97 – 1.95
- Day range
- 0.97 – 1.03
- Volume / Avg
- 756.50K / 488.25K
- Beta
- —
- Shares outstanding
- 61.92M
- Next earnings
- Nov 5, 2026
52-week range
PLRX stock today
On Oct 7, PLRX ended the session at $0.99, shedding $0.04 (3.88%), versus the S&P 500's 0.22% decline. At this level, PLRX sits near the bottom of its 52-week range of $0.97 to $1.95: 49.2% below the high, set on Oct 27, 2025 and 2.1% above the low. PLRX is down 18.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 33.1%.
Pliant Therapeutics has posted a net loss over the last twelve months (EPS of -$1.44), so its P/E ratio is not meaningful. Pliant Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Pliant Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2020
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.37
PLRX news
All PLRX newsPliant Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RNXTRenovoRx Inc. | 1.37 | -1.44% | $61.83M | vs PLRX |
| ATHEAlterity Therapeutics Limited ADR | 3.32 | -1.48% | $60.45M | vs PLRX |
| GOSSGossamer Bio Inc. | 10.18 | -5.57% | $62.26M | vs PLRX |
| BOLDBoundless Bio Inc. | 2.64 | +2.72% | $60.05M | vs PLRX |
| APLMApollomics Inc. Class A | 21.50 | -2.71% | $62.67M | vs PLRX |
| CNTBConnect Biopharma Holdings Limited | 0.9447 | +4.34% | $59.49M | vs PLRX |
| XLOXilio Therapeutics Inc. | 9.01 | +0.11% | $59.29M | vs PLRX |
| ACETAdicet Bio Inc. | 6.18 | -1.12% | $57.85M | vs PLRX |
Indexes, lists and sector
Pliant Therapeutics stock FAQ
What is Pliant Therapeutics's stock price today?
PLRX last traded at $0.99 as of Oct 7, 4:00 PM EDT, down 3.88% on the day. Prices are delayed at least 15 minutes.
When is Pliant Therapeutics's next earnings date?
Pliant Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.37.
What is the PLRX 52-week high?
The 52-week high for PLRX is $1.95 and the 52-week low is $0.97. The stock is currently 49.2% below its high.